Skip to main content
. 2017 Nov 17;8(66):110234–110256. doi: 10.18632/oncotarget.22622

Figure 10. Correlation between histopathological assessment of clinical samples and their LINC000273 expressions.

Figure 10

(A) Data revealed distinct difference in expression of LINC000273 with varying stages/types of neoplasia. Normal scored minimum relative expression of the LINC00273 followed by benign tissue or carcinoma in situ. Invasive samples exhibited maximum LINC00273 with internal difference varying with well differentiated, moderately differentiated and poorly differentiated conditions. (B) Various stages of oral cancer, as identified histopathologically is correlated with the degree of LINC00273 expression. (C) Graphical expression of the difference of LNCRNA in accordance to samples being Normal, Benign and Metastatic. Data shows the expression of this LINCRNA can be used not only as a molecular target to restrict metastasis but also in the field of diagnosis / staging of the disease. *p value<0.005 relative to Normal samples and ɸ p value<0.005 relative to Non-metastatic samples.